EpilepsyGTx
Developing gene therapies to transform the management of focal refractory epilepsy (FRE).
HQ location
Cambridge, United Kingdom
Website
Enterprise value
$40—60m
Company register number
loading funding rounds…
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads